Research and analysis

Herpes zoster (shingles) immunisation programme 2015 to 2016: evaluation report

Evaluation of the third year of the shingles vaccination programme in England from 2015 to 2016.

• From: Public Health England
• Published: 25 November 2016
• Last updated: 26 January 2017 — See all updates

Documents

Herpes zoster (shingles) immunisation programme 2015 to 2016: report for England

Ref: PHE publications gateway number: 2016461

PDF, 627 KB, 13 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage in England by age cohort, Clinical Commissioning Group and Local Authority: 1 September 2013 to 31 August 2016

MS Excel Spreadsheet, 230 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage by CCG, AT in England, September 2013 to November 2016

MS Excel Spreadsheet, 117 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage by CCG, England, September 2015 to May 2016

MS Excel Spreadsheet, 61.2 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage report, England, September 2015 to February 2016

PDF, 185 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage by CCG, England, September 2015 to February 2016

MS Excel Spreadsheet, 60.7 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage report, England, September 2015 to November 2015

PDF, 258 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage by CCG, England, September 2015 to May 2016

PDF, 279 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The shingles vaccination programme aims to reduce the incidence and severity of shingles in those targeted by the programme by boosting individuals’ pre-existing varicella zoster virus immunity.

This report highlights the lower coverage achieved in the routine and catch-up cohort in 2015 to 2016 compared with previous years. GPs are urged to continue to offer vaccinations to these cohorts as per current guidance, to improve protection in these age groups.

In the third year of the programme (2015 to 2016), the vaccine was offered to adults:

• aged 70 years on 1 September 2015 (born between 2 September 1944 and 1 September 1945)
• aged 78 years on 1 September 2015 (born between 2 September 1936 and 1 September 1937)

Last year’s report for comparison.

Published 25 November 2016
Last updated 26 January 2017 + show all updates

1. 26 January 2017

   Data file amended: Heading (column K) amended in the Local Team and Area Team worksheets.

2. 25 November 2016

   First published.